Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Contraception Clinical Trials

A listing of Contraception medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (7) clinical trials

Women's Health Research Ctr. is conducting a clinical research study of an investigational oral medication for birth control. Patient Inclusion Criteria: Females ages 18-40 years of age, sexually active, and have regular menstrual cycles are eligible for participation in a 12 month study for birth control. Patient Exclusion Criteria: Must ...

Phase

The objectives of this study are to evaluate the contraceptive efficacy, vaginal bleeding pattern (cycle control), and the general safety and acceptability of the 15 mg estetrol (E4)/3 mg drospirenone (DRSP) combination in healthy women aged 16 to 50 years.

Phase

Birth Control Study

Phase

Continuous Versus Cyclic Use of Oral Contraceptive Pills in Adolescents

Oral contraceptive pills have traditionally been prescribed in a cyclical manner, where there are 21-24 days of active pills and 4-7 days of placebo pills or a pill-free interval, creating a 28-day cycle. It has now been proven that as long as a woman has both estrogen and progesterone, her ...

Phase

E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - US/CA Study

The objectives of this study are to evaluate the contraceptive efficacy, vaginal bleeding pattern (cycle control), and the general safety and acceptability of the 15 mg estetrol (E4)/3 mg drospirenone (DRSP) combination in healthy women aged 16 to 50 years.

Phase

Mirena Extension Trial

The study is performed to assess if Mirena is effective and safe as a birth control method beyond 5 years of use. Further the menstrual blood loss (in women that had Mirena inserted for the indication heavy menstrual bleeding [HMB]) and safety will be assessed.

Phase

AMP002 Phase III Contraceptive Study

Through assessments including pelvic examination, laboratory procedures, and medical and gynecological history, subjects will be screened for eligibility in order to enroll approximately 1350 subjects into the study. After a screening period of up to 60 days, enrolled women will receive study drug. Each woman will participate in the study ...

Phase